Can small inefficiencies in one-carbon metabolism and thyroid-dependent erythropoiesis cause subtle macrocytosis without classic B12 deficiency?

Subclinical variations across thyroid-dependent and one-carbon metabolic pathways can subtly alter erythrocyte maturation and morphology, even in the absence of classic biochemical vitamin B12 deficiency.

Genetic and clinical drivers of macrocytosis

• Alterations without classic B12 deficiency: Subtle elevations in mean corpuscular volume (MCV) or red cell distribution width (RDW) can occur when both vitamin B12 and methylmalonic acid (MMA) are within normal reference ranges.
• Genetic modifiers: Polymorphisms such as the methionine synthase reductase (MTRR) A66G variant are linked to higher MCV, while transcobalamin II (TCN2) variants impair cellular cobalamin delivery. Variants in folate-related genes like MTHFD1 may also disrupt DNA synthesis during erythropoiesis, whereas DIO2 and PEMT variants remain mechanistically plausible but less clinically documented.

Integrated mechanistic pathways

• Erythroid differentiation: Thyroid hormone receptor alpha (TRα) signaling is directly required for terminal erythroid progenitor maturation and hemoglobin synthesis. Thyroid hormones also upregulate erythropoietin (EPO) expression by stabilizing hypoxia-inducible factor-1 (HIF-1).
• Metabolic feedback loop: Thyroid status directly regulates key one-carbon enzymes like MTHFR and methionine synthase, modulating the folate-dependent nucleotide synthesis required for rapidly dividing erythroblasts. Conversely, methylation intermediates like homocysteine can stimulate pituitary TSH synthesis, establishing a bidirectional regulatory axis between these systems.

Bottom line

Subtle macrocytosis can arise from coordinated genetic variations in cobalamin/folate pathways and thyroid-driven differentiation, occurring independently of a classic, MMA-elevated vitamin B12 deficiency.